Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

CATX holding history

Perspective Therapeutics, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CATX overviewAll 13F holders of CATXFull Q2 2026 holdings

Shares (Q2 2026)
59,133
Value
$201.6K
% of portfolio
<0.1%
Quarters held
17
Since Q1 2021
Holdings of CATX by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202659,133$201.6K<0.1%+59,133NewHolders
Q1 20260$00.0%−352,493−100.0%Sold outHolders
Q4 2025352,493$969.4K<0.1%+352,493NewHolders
Q2 20250$00.0%−163,460−100.0%Sold outHolders
Q1 2025163,460$348.2K<0.1%+163,460NewHolders
Q3 20240$00.0%−61,660−100.0%Sold outHolders
Q2 202461,660$614.8K<0.1%+29,914+94.2%AddedHolders
Q1 202431,746$38.0K<0.1%−275,000−89.7%ReducedHolders
Q4 2023306,746$123.0K<0.1%−60,900−16.6%ReducedHolders
Q3 2023367,646$101.0K<0.1%−69,280−15.9%ReducedHolders
Q2 2023436,926$292.0K<0.1%+20,400+4.9%AddedHolders
Q1 2023416,526$266.0K<0.1%+37,400+9.9%AddedHolders
Q4 2022379,126$94.0K<0.1%+7,000+1.9%AddedHolders
Q3 2022372,126$86.0K<0.1%−4,966−1.3%ReducedHolders
Q2 2022377,092$117.0K<0.1%−40,223−9.6%ReducedHolders
Q1 2022417,315$151.0K<0.1%−563,591−57.5%ReducedHolders
Q4 2021980,906$380.0K<0.1%−212,727−17.8%ReducedHolders
Q3 20211,193,633$753.0K<0.1%−1,386,666−53.7%ReducedHolders
Q2 20212,580,299$2.06M<0.1%−679,929−20.9%ReducedHolders
Q1 20213,260,228$3.55M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.